DISPARITIES IN PROSTATE CANCER SCREENING AND TREATMENT IN BLACK MEN

Authors

SHARON DRUMMOND, University of LynchburgFollow

Specialty

INTERNAL MEDICINE

Advisor

DR. MARY WALTON

Abstract

Disparities in Prostate Cancer Screening and Treatment in Black Men

ABSTRACT

The purpose of this article is to review the disparities and barriers in prostate screening and treatments in Black men and efforts to alleviate them. Black men are more likely to develop prostate cancer than all other races, and not only are Black men more likely to develop prostate cancer than other racial groups, but they are also more likely to die from the disease.¹ Men of African ancestry usually present with more advanced and aggressive tumors with a survival rate that is less favorable than White men.¹ Men with prostate cancer may receive various treatments based on stage, but there is a distinctive racial disparity in the treatment of localized disease.¹ Despite prostate cancer screening tools, diagnostics, and treatment advancements, disparities exist.¹ Difference also exists based on educational level, socioeconomic status, and geographic location.⁷ These factors in inequalities are associated with systemic access issues affecting the availability of care, provider awareness, personal patient views, and mistrust.⁷ Progress has been made in prostate cancer survival, treatment, and disparity, but more work is needed.⁷ Because the etiology of these disparities involves several factors, addressing the inequalities will take an integrative approach.⁷

Recommended Citation

DRUMMOND S. DISPARITIES IN PROSTATE CANCER SCREENING AND TREATMENT IN BLACK MEN. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2023; 5(1).